Elicitation of predictable immune responses by using live bacterial vectors

Area of Science:

• Vaccinology
• Microbiology
• Immunology

Background:

• There is a growing demand for vaccines that are both effective and affordable.
• Attenuated bacterial carriers present a promising solution, offering lower production costs and enhanced immunogenicity compared to traditional vaccines.
• Advances in understanding bacterial physiology and host immune responses allow for precise control over vaccine-induced immunity.

Purpose of the Study:

• To review the current landscape of attenuated bacterial carrier systems for vaccine development.
• To explore strategies for modulating immune responses elicited by these novel vaccine platforms.
• To highlight the potential of bacterial carriers in delivering both antigen and DNA vaccines.

Main Methods:

• Review of scientific literature on bacterial vaccine carriers.
• Analysis of strategies for immune response modulation.
• Discussion of applications in infectious disease and tumor vaccination.

Main Results:

• Attenuated bacteria serve as effective carriers for antigens and DNA vaccines.
• Bacterial carriers stimulate more potent and durable immune responses than non-replicating vaccines.
• Various strategies exist to tailor immune responses for specific needs.

Conclusions:

• Attenuated bacterial carriers represent a versatile and cost-effective platform for developing next-generation vaccines.
• These systems hold significant promise for combating infectious agents and tumors.
• Further research into modulating immune responses will optimize their therapeutic potential.